Behavioural and neurochemical dysfunction in the circling (ci) rat: A novel genetic animal model of a movement disorder

Neuroscience

Volumn 74, Issue 4, 1996, Pages 1135-1142

  Loscher W ^a   Richter, A ^a   Nikkhah, G ^b   Rosenthal, C ^b   Ebert, U ^a   Hedrich, H J ^c  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b NORDSTADT HOSPITAL   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Circling rat; Dopamine; Movement disorders; Parkinson's disease

Indexed keywords

AMPHETAMINE; APOMORPHINE; AMINO ACID RECEPTOR STIMULATING AGENT; ANTIPARKINSON AGENT; CENTRAL STIMULANT AGENT; DIZOCILPINE MALEATE; DOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MOTOR DYSFUNCTION; MUTANT; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; ANIMAL; ANIMAL BEHAVIOR; BRAIN LEVEL; DRUG EFFECT; FORELIMB; GENETICS; LEWIS RAT; METABOLISM; MOTOR ACTIVITY; MOTOR PERFORMANCE; MUTATION; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; STEREOTYPY;

AMPHETAMINE; ANIMALS; ANTIPARKINSON AGENTS; APOMORPHINE; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM STIMULANTS; DIZOCILPINE MALEATE; DOPAMINE; EXCITATORY AMINO ACID AGONISTS; FEMALE; FORELIMB; MALE; MOTOR ACTIVITY; MOTOR SKILLS; MOVEMENT DISORDERS; MUTATION; RATS; RATS, INBRED LEW; STEREOTYPED BEHAVIOR;

EID: 0030250998     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(96)00248-5     Document Type: Article

References (40)

1. 1. Ali S. F., Newport G. D. and Bracha H. S. (1994) Phencyclidine and (+)-MK-801-induced circling preference - correlation with monoamine levels in striatum of the rat brain. Neurotoxic. Teratol. 16, 335-342.
2. 2. Bracha H. S., Shults C., Glick S. D. and Kleinman J. E. (1987) Spontaneous asymmetric circling behavior in hemi-parkinsonism; a human equivalent of the lesioned-circling rodent behavior. Life Sci. 40, 1127-1130.
3. 3. Carey R. J. (1986) Relationship of changes in spontaneous motor activity to spontaneous circling in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra. Expl Neurol. 92, 591-600.
4. 4. Deerberg F., Kaspareit J. and Reetz I. C. (1989) Circling (ci), a new neurological mutant in the rat. Rat Newslett. 21, 19.
5. 5. Driscoll P. (1992) Genetically Defined Animal Models of Neurobehavioral Dysfunctions. Birkhäuser, Boston.
6. 6. Fornaguera J., Carey R., Huston J. and Schwarting R. (1995) Behavioral asymmetries and recovery related with different degrees of unilateral striatal dopamine depletion. Soc. Neurosci. Abstr. 20, 175.
7. 7. Glick S. D., Jerussi T. P. and Fleisher L. N. (1976) Turning in circles: the neuropharmacology of rotation. Life Sci. 18, 889-896.
8. 8. Goto S., Korematsu K., Inoue N., Yamada K., Oyama T., Nagahiro S. and Ushio Y. (1993) N-Methyl-d-aspartate receptor antagonist MK-801 induced circling behavior in rats with unilateral striatal ischemic lesions or nigral 6-hydroxydopamine lesions. Acta neuropath. 86, 480-483.
9. 9. Hedrich H.-J. (1990) Genetic Monitoring of Inbred Strains of Rats. Gustav Fischer, Stuttgart.
10. 10. Hudson J. L., van Horne C. G., Strömberg I., Brock S., Clayton J., Masserano J., Hoffer B. J. and Gerhardt G. A. (1993) Correlation of apomorphine-and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res. 626, 167-174.
11. 11. Ikebe S., Tanaka M. and Ozawa T. (1995) Point mutations of mitochondrial genome in Parkinson's disease. Molec. Brain Res. 28, 281-295.
12. 12. Jellinger K. (1987) The pathology of parkinsonism. In Movement Disorders 2 (eds Marsden C. D. and Fahn S.), pp. 124-165. Butterworths, London.
13. 13. Kaakkola S. and Teravainen H. (1990) Animal models of parkinsonism. Pharmac. Toxic. 67, 95-100.
14. 14. Langer S. Z. and Lehmann J. (1988) Presynaptic receptors on catecholamine neurones. In Catecholamines I (eds Trendelenburg U. and Weiner N.), pp. 419-508. Springer, Berlin.
15. 15. Langston J. W. (1989) Current theories on the cause of Parkinson's disease. J. Neurol. Neurosurg. Psychiatry Special Suppl., 13-17.
16. 16. Löscher W., Annies R. and Hönack D. (1991) The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats. Neurosci. Lett. 128, 191-194.
17. 17. Löscher W., Annies R. and Richter A. (1994) Marked regional disturbances in brain metabolism of monoaminergic neurotransmitters in the genetically dystonic hamster. Brain Res. 658, 199-208.
18. 18. Löscher W. and Hönack D. (1992) The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems. Eur. J. Pharmac. 215, 199-208.
19. 19. Löscher W., Vetter M., Müller F., Böhme G. and Stoltenburg-Didinger G. (1984) Development of a synaptosomal model to determine drug-induced in vivo changes in GABA-levels of nerve endings in 11 brain regions of the rat. Neurochem. Int. 6, 441-451.
20. 20. Lyon M. F. and Searle A. G. (1989) Genetic Variants and Strains of the Laboratory Mouse. Oxford University Press, Oxford.
21. 21. Marshall J. F. and Ungerstedt U. (1976) Supersensitivity to apomorphine following destruction of the ascending dopamine neurons: quantification using the rotational model. Eur. J. Pharmac. 41, 361-367.
22. 22. Montoya C. P., Astell S. and Dunnett S. B. (1990) Effects of nigral and striatal grafts on skilled forelimb use in the rat. Prog. Brain Res. 82, 459-466.
23. 23. Montoya C. P., Campbell H. L., Pemberton K. D. and Dunnett S. B. (1991) The "staircase test": a measure of independent forelimb reaching and grasping abilities in rats. J. Neurosci. Meth. 36, 2-3.
24. 24. Nikkhah G., Cunningham M. G., McKay R. and Björklund A. (1995) Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. II. Transplant-induced behavioral recovery. J. Neurosci. 15, 3562-3570.
25. 25. Nikkhah G., Duan W.-M., Knappe U., Jödicke A. and Björklund A. (1993) Restoration of complex sensorimotor behavior and skilled forelimb use by a modified nigral cell suspension transplantation approach in the rat Parkinson model. Neuroscience 56, 33-43.
26. 26. Olsson M., Nikkhah G., Bentlage C. and Björklund A. (1995) Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J. Neurosci. 15, 3863-3875.
27. 27. Payami H., Larsen K., Bernard S. and Nutt J. (1994) Increased risk of Parkinson's disease in parents and siblings of patients. Ann. Neurol. 36, 659-661.
28. 28. Pycock C. J. (1980) Turning behaviour in animals. Neuroscience 5, 461-514.
29. 29. Ratty A. K., Fitzgerald L. W., Titeler M., Glick S. D., Mullins J. J. and Gross K. W. (1990) Circling behavior exhibited by a transgenic insertional mutant. Molec. Brain Res. 8, 355-358.
30. 30. Roffler-Tarlov S. and Graybiel A. M. (1984) Weaver mutation has differential effects on the dopamine-containing innervation of the limbic and nonlimbic striatum. Nature 307, 62-66.
31. 31. Schmidt M., Sawyer B. D., Perry K. W., Fuller R. W., Foreman M. M. and Ghetti B. (1982) Dopamine deficiency in the weaver mutant mouse. J. Neurosci. 2, 376-380.
32. 32. Shoulson I. (1989) Experimental therapeutics directed at the pathogenesis of Parkinson's disease. In Drugs for the Treatment of Parkinson's Disease (ed. Calne D. B.), pp. 289-311. Springer, Berlin.
33. 33. Triarhou L. C. and Ghetti B. (1987) Neuroanatomical substrate of behavioral impairment in weaver mutant mice. Expl Brain Res. 68, 434-436.
34. 34. Ungerstedt U. (1968) 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur. J. Pharmac. 5, 107-110.
35. 35. Ungerstedt U. (1971) Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigrostriatal dopamine system. Acta physiol. scand. 82 Suppl. 367, 69-93.
36. 36. Ungerstedt U. (1971) Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta physiol. scand. 82 Suppl. 367, 49-68.
37. 37. Ungerstedt U. and Arbuthnott G. (1970) Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res. 24, 485-493.
38. 38. Ungerstedt U., Avemo A., Avemo E., Ljungberg T. and Ranje C. (1973) Animal models of parkinsonism. Adv. Neurol. 3, 257-271.
39. 39. Vieregge P. (1994) Genetic factors in the etiology of idiopathic Parkinson's disease. J. neural Transm., Parkinson's Disease and Dementia 8, 1-37.
40. 40. Whishaw I. Q., Pellis S. M. and Gorny B. P. (1992) Skilled reaching in rats and humans: evidence for parallel development or homology. Behav. Brain Res. 47, 59-70.